You are here
As a member of Core Clinical Sites, Development Operations, PGRD, Ying is responsible for clinical project planning and driving the delivery of clinical study milestones from First in Human to Proof of Concept, and supporting clinical pharmacology studies across all phases. Ying started her career with Pfizer in 1998 with Pharmaceutical Sciences. She later joined Global Clinical Sciences and worked on evolving processes and systems and ensured submission quality of clinical pharmacology study outputs for G/NL and NY sites before joining her current group. Ying has served on APAG (Asian Pacific Americans Group) including chairing the Asia Business Development Committee G/NL chapter in 2009. Ying holds a science degree (M.S), a Regulatory Affairs/Quality Assurance Clinical Trials Management Certificate, a PMP Certificate, and a MBA.
As a Market Researcher fellow, Ying will be involved in assessing the readiness of the country government, investigator sites, contract research organizations, and other sponsors to institute AAHRPP accreditation in China. Through interactions with government officials and researchers to educate and advance ethical and quality clinical research, Ying will help to develop the accreditation development plan for China, and a business model to persuade and increase the number of sites in China to seek accreditation.
From her fellowship, Ying hopes to bring back to Pfizer a greater understanding of the clinical trial sites and conditions in emerging markets. She believes this experience will provide broader global perspectives and first-hand knowledge that helps the ongoing work to increase access to healthcare products and services. Working as a pioneer for AAHRPP in new and under–resourced settings, Ying anticipates challenges and believes that as a result, honed leadership skills, influencing and planning skills will be among the many benefits she can bring back to her work.
AAHRPP is a non–profit organization that accredits high–quality human research protection programs in order to promote excellent, ethically sound research. Through partnerships with research organizations, researchers, sponsors, and the public, AAHRPP encourages effective, efficient, and innovative systems of protection for human research participants.